Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early vs Standard Epoetin Alfa for Anemia in Cancer Patients
NCT00216541Phase 4Completed
- Sponsor
- Johnson & Johnson
- Start
- Aug 2003
- Modality
- Biologic, rProtein (Recombinant Protein)
01
Overview
A Phase 4 trial of epoetin alfa in anemia, sponsored by Johnson & Johnson. Started Aug 2003; status: completed.
02
Drugs
epoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00216541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00216541.